These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 33792662)
1. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2. Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662 [TBL] [Abstract][Full Text] [Related]
2. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963 [TBL] [Abstract][Full Text] [Related]
3. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483 [TBL] [Abstract][Full Text] [Related]
4. Microglia as modulators of exosomal alpha-synuclein transmission. Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269 [TBL] [Abstract][Full Text] [Related]
5. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1. Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology. Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296 [TBL] [Abstract][Full Text] [Related]
7. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease? Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049 [TBL] [Abstract][Full Text] [Related]
8. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease. Zheng T; Zhang Z Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease. Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431 [TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation and protein pathology in Parkinson's disease dementia. Kouli A; Camacho M; Allinson K; Williams-Gray CH Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323 [TBL] [Abstract][Full Text] [Related]
11. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Chang C; Lang H; Geng N; Wang J; Li N; Wang X Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198 [TBL] [Abstract][Full Text] [Related]
12. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327 [TBL] [Abstract][Full Text] [Related]
13. Exosomes from patients with Parkinson's disease are pathological in mice. Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715 [TBL] [Abstract][Full Text] [Related]
14. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Kim C; Ho DH; Suk JE; You S; Michael S; Kang J; Joong Lee S; Masliah E; Hwang D; Lee HJ; Lee SJ Nat Commun; 2013; 4():1562. PubMed ID: 23463005 [TBL] [Abstract][Full Text] [Related]
15. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia. Dai M; Yan L; Yu H; Chen C; Xie Y J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922 [TBL] [Abstract][Full Text] [Related]
16. Preferential microglial activation associated with pathological alpha synuclein transmission. Kim YE; Lai TT; Kim YJ; Jeon B J Clin Neurosci; 2020 Nov; 81():469-476. PubMed ID: 33222964 [TBL] [Abstract][Full Text] [Related]
17. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995 [TBL] [Abstract][Full Text] [Related]
18. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease. Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T Front Immunol; 2021; 12():719807. PubMed ID: 34691027 [TBL] [Abstract][Full Text] [Related]
20. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis. Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]